🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📣#ESMO25: 🔬 Your opportunity for global impact. Submit your abstract and share your findings with the world’s leading oncology experts. ⏰ Abstract deadline 13 May 2025 🔗ow.ly/fp2f50VusBO

Delighted to invite star colleague arsela prelaj as keynote speaker to the Annual Beaumont RCSI Cancer Centre Conference, May 22🇮🇪 Looking forward to institutional collaborations on AI & cancer, &learning about novel projects like I3LUNG Organisation of European Cancer Institutes Beaumont Hospital RCSI Research and Innovation #LCSM

⬇️ these are fascinating data quantifying resources needed to do clinical trials. Between 2018 and 2024, budgets ⬆️, #FTE ⬆️, #trials ⬆️, but enrollment ⬇️? I missed this session live; grateful for opportunities to view virtually after the annual meeting! #AACR25 AACR

Excited to be in Athens 🇬🇷 for the ESMO - Eur. Oncology Advanced Course in NSCLC Congrats to chairs Giannis Mountzios Helena Linardou Solange Peters for the opportunity to be here with this stellar faculty 🇮🇪 Looking forward to a few days of excellent learning ESMO - Eur. Oncology Beaumont RCSI Cancer Centre #LCSM

Now the incredible Mariam Jamal-Hanjani presenting data from the TRACERx Peace cohorts defining the metastatic cascade in Nsclc ⁦Science and Innovation at Cancer Research UK⁩ ⁦UCL Cancer Institute⁩ ⁦The Crick⁩

An amazing 1st day of the ESMO - Eur. Oncology advanced course in early-stage NSCLC here in Athens, with a stellar faculty and amazing delegates from 20 countries! Lots of brainstorming and new collaborations!! 🙏Great co-hosts Helena Linardou Solange Peters #LCSM #some IASLC OncoAlert

An outstanding first day at the ESMO - Eur. Oncology Advanced Course in NSCLC: - 13 state-of-the-art talks from screening to stage I-III NSCLC - 64 participants from 20 countries 🇮🇪 - building collaborations & community Can’t wait for day 2! Beaumont RCSI Cancer Centre #IrishLungCancerAlliance #LCSM

Well done to ❁ Saoirse ❁ presenting her wonderful work #AACR25 Thank you to All-Island Cancer Research Institute (AICRI) for funding this work. Beaumont RCSI Cancer Centre RCSI University Of Limerick

Superb day 2 of the ESMO - Eur. Oncology Advanced Course in NSCLC: - patient selection & next steps in neoadj chemoIO Solange Peters - disparities in clinical trials Helena Linardou - new trials designs for early stage Anne-Marie Dingemans EORTC Going home with full 🧠 & ❤️! Til next year🇬🇷

Great work by Robyn Stanley presenting her work on #lungcancer at #AACR2025 Beaumont RCSI Cancer Centre RCSI

🎥 On demand:Expert insights on TROP2-targeted ADCs in #NSCLC from #ELCC2025! Join Profs. Garassino, Naidoo & Planchard as they discuss: ✅ Latest trial data ✅ Biomarker challenges ✅ Side-effect management 📺 touchoncologyime.org/trop2-adc-nscl… Marina Garassino Jarushka Naidoo d.planchard

Our DART team. DART hits the target 🎯🎯Sandip Patel, PI; Young Chae, Translational PI; Early Therapeutics and Rare Cancers SWOG committee. 1000 sites; 53 cohorts, ~25 positive cohorts. NCCN guideline changes; NCI Director award; important—new nivo/ipi option for rare cancers!

#LungHealthCheck was at Fingallians GAA tonight, for a community information evening ahead of the start of the Lung Health Check Ireland pilot Great to see a full house! interested in giving the lungs the care they deserve🫁 Beaumont RCSI Cancer Centre Irish Cancer Society RCSI Beaumont Hospital

Excited to take on this new role and follow in the footsteps of Jeff Bradley, MD!!

Real-world data of adv EGFR+ NSCLC JTO & JTO CRR: - 1323pts (concertAI, Flatiron, COTA databases) - mrwOS 28.6m - mOS of high risk grps: PS2+ 18.1m, BM 24.3m, liver mets 19.3m, p53 co-mtn 25.7m - 58% alive at 2yrs, 18% 5yrs Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ OncoAlert #LCSM jto.org/article/S1556-…

Honored to represent University Health Network and @PMCancerCentre at #AATS2025. Our ctDNA Lung DETECT Study adds to the growing evidence supporting the utility of ctDNA in early-stage NSCLC #AATS25 #AATS #ctDNA

Does #immunotherapy impact on patterns of cardiotoxicity in #lungcancer radiotherapy? ➡️ Maybe… #ESTRO25

Real world outcomes in pts with relapse after durvalumab consolidation post CRT for stage III NSCLC Lung Cancer Journal. With chemo-immunotherapy, PFS 12m; with platinum-based chemo alone, PFS 4.1m; non-platinum based chemo PFS 2.7m; targeted therapy PFS 6m. lungcancerjournal.info/article/S0169-…

Wonderful to watch Corinne Faivre-Finn receive the ESTRO Breur award yesterday and deliver an inspirational talk on women in leadership! #ESTRO25

Fascinating paper Nature Cancer on mechanisms of resistance to TIL in NSCLC: - serial multiomic analysis, 16pt TIL trial - subclonal neoAg lost at progression - LOH of pMHC in KRAS-specific Tcells at progression Ben Creelan, MD Moffitt Cancer Center OncoAlert #LCSM nature.com/articles/s4301…